SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Epigral

BSE: 543332 30 Sep 2025
Commodities
₹ 1695
Epigral Limited specializes in Specialty Chemicals within the Commodities sector.

Epigral - Share Price & Details

Market Cap
₹7,158
High /Low
2,408 / 1,502
Stock P/E
16.6
Book Value
₹441.0
Dividend Yield
0.36
ROCE
25.1
ROE
₹22.6
Face Value
10.0
PEG Ratio
1.37
EVEBITDA
₹10.7
Debt
593
CMP / FCF
46.3
Debt to equity
₹0.31
NP Ann
358
High price all time
2,408
Piotroski score
₹8.0
Graham Number
1,001
No. Eq. Shares
4.31
Net CF
₹15.5
Net profit
433
Price to book value
3.76
Interest Coverage
₹9.29
Low price all time
386.0
Industry PE
33.6
Reserves
₹1,861
Free Cash Flow
₹254

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
06 May 2025 Emkay Global Financial Services Buy ₹1,778.15 ₹2,450 38.2% moneycontrol View
01 Jul 2024 Emkay Global Financial Services Buy ₹1,460.25 ₹2,000 -4.5% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
SOUTHERN GAS LTD.NANANANA0.060.03
INDO GULF INDUSTRIES LTD.NANANANA0
Epigral Limited6147.91604.16065.437.187,15816.6
DHANUKA AGRITECH LTD.5363.32555.035282.8812.31684323.4
Chemplast Sanmar Limited5006.6-284.24952.8-1.86818

Peer Comparison Chart


About Epigral

Epigral Limited, with Security Code 543332, is a leading player in the Specialty Chemicals industry, categorized under the Commodities sector, offering Equity instruments.


Order Book


Latest News

Epigral CFO Sanjay Jain steps down

(08 Sep 2025)
Epigral announced that its chief financial officer (CFO) & key managerial personnel (KMP), Sanjay Surendra Jain, has tendered his...
Read more →

Epigral Outperforms Specialty Chemicals Sector Amid Broader Market Fluctuations

(24 Aug 2025)
Epigral, a midcap specialty chemicals company, has experienced notable gains, outperforming its sector significantly.
Read more →

Epigral Limited Releases Q1 FY26 Earnings Call Transcript

(07 Aug 2025)
Epigral Ltd ( ($IN:EPIGRAL) ) just unveiled an announcement. Epigral Limited has released the transcript of its Q1 FY26 earnings conference call,...
Read more →

Epigral Limited Just Recorded A 98% EPS Beat: Here's What Analysts Are Forecasting Next

(06 Aug 2025)
NSEI:EPIGRAL 1 Year Share Price vs Fair Value Explore Epigral's Fair Values from the Community and select yours As you...
Read more →

Epigral reports Q1 FY26 PAT at Rs. Revenue stood at Rs.160 Cr

(06 Aug 2025)
However PAT excluding deferred tax liability benefit stood at Rs. 79 crore as against Rs. 86 crore in Q1FY25. Epigral Limited (Epigral)...
Read more →

Epigral Limited (543332) Gets Regulatory Approval - Maximize gains with data-driven stock picks

(04 Aug 2025)
Epigral Limited (543332) Gets Regulatory Approval ✌️【Market Focus】✌️ Free real-time alerts and market analysis to help you make timely...
Read more →